The following is a summary of “Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Cabometyx is approved for treating well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 years and older ... They can cause painful rash in the hands and feet, ...

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Steve Jobs had what is called a neuroendocrine pancreatic tumor, a type that accounts for fewer than 5% of pancreatic cancers and, experts say, differs substantially from the more common kind.

“Franklin’s official cause of death was due to advance pancreatic cancer of the neuroendocrine type, which was confirmed by Franklin’s oncologist, Dr. Philip Phillips of Karmanos Cancer ...

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs.

There are two main types of pancreatic cancer, based on the type of cell that the tumor develops in. The two main types are ...

Cabozantinib significantly delayed disease progression in advanced pancreatic and extra-pancreatic neuroendocrine tumors, as shown in the phase 3 CABINET trial. The trial demonstrated a median PFS ...